Tegwondo: Development of a novel near-continuous dose-dense temozolomide regimen for the treatment of recurrent brain tumorsHerwig Strik, Mathias Bähr, Cathryn H. Bock et al.|Journal of Clinical Oncology|2008Cited by 7